Prognostic Value of Serum Neurofilaments in Patients with Clinically Isolated Syndromes

İpek Güngör Doğan

DOI: 10.4274/tnd.2019.97720

Issue: 2019, Volume 25 - Issue 3
0 284

The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results

Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale

DOI: 10.4274/tnd.2019.75725

Issue: 2019, Volume 25 - Issue 2
0 276

Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis

Halil Önder

DOI: 10.4274/tnd.2019.05925

Issue: 2019, Volume 25 - Issue 2
0 243

Neuroanatomy of Postural Stability: Links to Parkinson’s Disease

Burak Erdeniz, David Selveraj, Merve Bulut

DOI: 10.4274/tnd.2018.46793

Issue: 2019, Volume 25 - Issue 1
0 296

Analysis of Peripapillary Retinal Nerve Fiber Layer and Macular Volume in Patients with Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Healthy Controls Using Spectral Domain Optical Coherence Tomography in a Turkish Cohort

Ayşe İlksen Çolpak, Duygu Gülmez Sevim, Aslı Tuncer, Sevda Diker, Rana Karabudak, Sibel Kadayıfçılar, Tülay Kansu

DOI: 10.4274/tnd.2018.33230

Issue: 2019, Volume 25 - Issue 1
0 271

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis

Miraç Ayşen Ünsal

DOI: 10.4274/tnd.2019.00187

Issue: 2019, Volume 25 - Issue 1
0 291

Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years

Nefati Kıylıoğlu

DOI: 10.4274/tnd.79836

Issue: 2018, Volume 24 - Issue 3
0 271

Posterior Auricular Muscle Response: Observations in Brainstem Lesions

Yeşim Gülen Abanoz, Yasin Abanoz, Yasemin Akıncı, Ayşegül Gündüz, Eser Buluş, Melih Tütüncü, Sabahattin Saip, Meral Erdemir Kızıltan

DOI: 10.4274/tnd.57255

Issue: 2018, Volume 24 - Issue 3
0 290

Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis

Joob Beuy, Viroj Wiwanitkit

DOI: 10.4274/tnd.86977

Issue: 2018, Volume 24 - Issue 2
0 242

The Effects of a Postural Balance Training Program on Balance, Gait and Health-Related Quality of Life in Patients with Essential Tremor

Bilge Kara, Turhan Kahraman, Melda Soysal Tomruk, Berril Dönmez Çolakoğlu, Özge Yılmaz Küsbeci

DOI: 10.4274/tnd.76148

Issue: 2018, Volume 24 - Issue 1
0 346

Mortality in Patients with Multiple Sclerosis

Sümeyra Şamlı, Murat Kürtüncü

DOI: 10.4274/tnd.15921

Issue: 2018, Volume 24 - Issue 1
0 329

Fampridine Therapy in Multiple Sclerosis: We Should Think Twice!

Mohamed S A Mohamed

DOI: 10.4274/tnd.65882

Issue: 2018, Volume 24 - Issue 1
0 213

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir

DOI: 10.4274/tnd.62144

Issue: 2017, Volume 23 - Issue 4
0 317

Quality of Life, Coping, and Social Support in Patients with Multiple Sclerosis: A Pilot Study

Oğuzhan Zengin, Ercüment Erbay, Buğra Yıldırım, Özgür Altındağ

DOI: 10.4274/tnd.37074

Issue: 2017, Volume 23 - Issue 4
0 385

Flow Cytometry Analysis of Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis

Vuslat Yılmaz, Deniz Ak Tura, Canan Ulusoy, Duygu Özkan Yaşargün, Suzan Adın Çınar, Recai Türkoğlu

DOI: 10.4274/tnd.87523

Issue: 2017, Volume 23 - Issue 4
0 270

Acute Spinal Pseudoathetosis

Mehmet Fevzi Öztekin, Dilara Mermi Dibek

DOI: 10.4274/tnd.27167

Issue: 2017, Volume 23 - Issue 4
0 216

Weight Loss and Fingolimod

Nefati Kıylıoğlu

DOI: 10.4274/tnd.87528

Issue: 2017, Volume 23 - Issue 4
0 204

The Effect of Ocrelizumab in the Treatment of Multipl Sclerosis

Şenay Yıldız Çelik

DOI: 10.4274/tnd.71354

Issue: 2017, Volume 23 - Issue 3
0 232

Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis

Ahmed Serkan Emekli

DOI: 10.4274/tnd.90018

Issue: 2017, Volume 23 - Issue 3
0 199

The Predictive Role of NEDA in the Long-Term Course of Multiple Sclerosis

Özgü Kizek

DOI: 10.4274/tnd.65391

Issue: 2017, Volume 23 - Issue 1
0 226